Cargando…

XPG is a novel biomarker of clinical outcome in advanced non-small-cell lung cancer

Objective: Polymorphisms in XPG were considered to contribute to the clinical outcome of patients receiving platinum drug chemotherapy. We investigated the impact of several potential SNPs of XPG on the efficacy of platinum-based chemotherapy in NSCLC patients. Methods: A total of 433 patients were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuli, Yi, Zhe, Sun, Xia, WANG, Siqing, LI, Zhenxuan, WU, Yu-hua, ZHU, Bing, Sun, Jun-wei, Cui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publicaitons 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809298/ https://www.ncbi.nlm.nih.gov/pubmed/24353624

Ejemplares similares

XPG: a multitasking genome caretaker
por: Muniesa-Vargas, Alba, et al.
Publicado: (2022)

XPG rs2296147 T>C polymorphism predicted clinical outcome in colorectal cancer
por: Wang, Fang, et al.
Publicado: (2016)

Expression of XPG Protein in the Development, Progression and Prognosis of Gastric Cancer
por: Deng, Na, et al.
Publicado: (2014)

Domain swapping between FEN-1 and XPG defines regions in XPG that mediate nucleotide excision repair activity and substrate specificity
por: Hohl, Marcel, et al.
Publicado: (2007)

XPG gene polymorphisms and cancer susceptibility: evidence from 47 studies
por: Huang, Jiawen, et al.
Publicado: (2017)

The association of XPG and MMS19L polymorphisms response to chemotherapy in osteosarcoma
por: Zhao, Yi-lei, et al.
Publicado: (2013)

Association between the polymorphisms in XPG gene and gastric cancer susceptibility in Chinese populations: A PRISMA-compliant meta-analysis
por: Xia, Jun, et al.
Publicado: (2017)

Predictive value of XPG rs2296147T>C polymorphism on clinical outcomes of cancer patients
por: Wang, Yuhan, et al.
Publicado: (2016)

Association of XPG rs2094258 polymorphism with gastric cancer prognosis
por: Wang, Xiao-Qin, et al.
Publicado: (2019)

Association between XPG polymorphisms and stomach cancer susceptibility in a Chinese population
por: Chen, Yun‐Zhi, et al.
Publicado: (2016)

XPG is Modulated by miR-4715-3p and rs873601 Genotypes in Lung Cancer
por: Yu, WeiLing, et al.
Publicado: (2021)

The association between XPG polymorphisms and cancer susceptibility: Evidence from observational studies
por: Han, Cuihong, et al.
Publicado: (2017)

A prospective study of biomarker-guided chemotherapy in patients with non-small cell lung cancer
por: Zhang, Qiang, et al.
Publicado: (2014)

Association of potentially functional variants in the XPG gene with neuroblastoma risk in a Chinese population
por: He, Jing, et al.
Publicado: (2016)

The Role of XPG in Processing (CAG)(n)/(CTG)(n )DNA Hairpins
por: Hou, Caixia, et al.
Publicado: (2011)

Mediator links transcription and DNA repair by facilitating Rad2/XPG recruitment
por: Eyboulet, Fanny, et al.
Publicado: (2013)

Xpg limits the expansion of haematopoietic stem and progenitor cells after ionising radiation
por: Avila, Alush I., et al.
Publicado: (2016)

Transcriptional Stress Induces Chromatin Relocation of the Nucleotide Excision Repair Factor XPG
por: Scalera, Claudia, et al.
Publicado: (2021)

Association between genetic variants in the XPG gene and gastric cancer risk in a Southern Chinese population
por: Hua, Rui-Xi, et al.
Publicado: (2016)

XPG Gene Polymorphisms Contribute to Colorectal Cancer Susceptibility: A Two-Stage Case-Control Study
por: Hua, Rui-Xi, et al.
Publicado: (2016)

XPG rs873601 G>A contributes to uterine leiomyoma susceptibility in a Southern Chinese population
por: Liu, Zhi-Qin, et al.
Publicado: (2018)

Cell-Autonomous Progeroid Changes in Conditional Mouse Models for Repair Endonuclease XPG Deficiency
por: Barnhoorn, Sander, et al.
Publicado: (2014)

XPG gene rs751402 C>T polymorphism and cancer risk: Evidence from 22 publications
por: Zhou, Haixia, et al.
Publicado: (2017)

Human XPG nuclease structure, assembly, and activities with insights for neurodegeneration and cancer from pathogenic mutations
por: Tsutakawa, Susan E., et al.
Publicado: (2020)

Functional interplay between Mediator and RNA polymerase II in Rad2/XPG loading to the chromatin
por: Georges, Adrien, et al.
Publicado: (2019)

The splicing factor XAB2 interacts with ERCC1-XPF and XPG for R-loop processing
por: Goulielmaki, Evi, et al.
Publicado: (2021)

Yeast RAD2, a homolog of human XPG, plays a key role in the regulation of the cell cycle and actin dynamics
por: Kang, Mi-Sun, et al.
Publicado: (2013)

XPG rs17655 G>C polymorphism associated with cancer risk: evidence from 60 studies
por: Zhao, Jie, et al.
Publicado: (2018)

Risk Modulation of Oral Pre Cancer and Cancer with Polymorphisms in XPD and XPG Genes in North Indian Population
por: Nigam, Kumud, et al.
Publicado: (2019)

A scanning-to-incision switch in TFIIH-XPG induced by DNA damage licenses nucleotide excision repair
por: Bralić, Amer, et al.
Publicado: (2022)

Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis
por: Wang, Huan, et al.
Publicado: (2014)

Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer
por: Sun, Dantong, et al.
Publicado: (2020)

Erratum to: Different efficacy of EGFR tyrosine kinase inhibitors and prognosis in patients with subtypes of EGFR-mutated advanced non-small cell lung cancer: a meta-analysis
por: Wang, Huan, et al.
Publicado: (2014)

Association study between XPG Asp1104His polymorphism and colorectal cancer risk in a Chinese population
por: Du, Haina, et al.
Publicado: (2014)

Comparative evaluation of XPD and XPG gene polymorphism in oral squamous cell carcinoma and tobacco chewers: An observational study
por: Shrivastava, Prabhanshu, et al.
Publicado: (2022)

Prognostic biomarkers correlated with immune infiltration in non‐small cell lung cancer
por: Xu, Fei, et al.
Publicado: (2022)

Outcomes and toxicity of stereotactic body radiation therapy for advanced stage ultra‐central non‐small cell lung cancer
por: Cong, Yang, et al.
Publicado: (2019)

Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers
por: Russano, Marco, et al.
Publicado: (2023)

WEE1 kinase polymorphism as a predictive biomarker for efficacy of platinum-gemcitabine doublet chemotherapy in advanced non-small cell lung cancer patients
por: Liu, Di, et al.
Publicado: (2015)

Metagenome association study of the gut microbiome revealed biomarkers linked to chemotherapy outcomes in locally advanced and advanced lung cancer
por: Zhao, Zhe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_riii485gqduifhfietesbl1fo3